Andrew has over 20 years of experience advising executive teams and boards of directors on long-term corporate positioning and high-stakes situations including cyberattacks, initial public offerings, litigation, mergers & acquisitions, proxy contests, and senior management changes.

Engagements include:

• Providence Equity Partners on its long-term corporate positioning and transaction announcements
• Takeda Pharmaceuticals on its acquisition of Shire and listing on the NYSE
• HCP’s spin-off of its skilled nursing and assisted living assets

Andrew also serves on the Board of Directors of SVC. From 2006 to 2009, he worked in the firm’s San Francisco office. He joined SVC in 1998 from Gavin Anderson & Company.

Andrew received a B.A. in English from Connecticut College.

Get In Touch

acole@sardverb.com vCard